SARISA

website

https://www.sarisatherapeutics.com/

Leadership

Danny Cunagin, Chief Executive Officer
Brian Ross, PhD, Chief Scientific Officer
Jake Petersburg, PhD, Sr. Research Scientist

Founded

2016

Industry

Kinase Inhibitor Technology

Sarisa is a drug development company focused on developing therapies that utilize the lymphatic system to treat a number of conditions including cancer and autoimmune disorders. The company’s small molecule approach is two-fold, (1) bi-specific disease inhibition in a single molecule and (2) limiting off-target toxicity with novel lymphatic metabolism. Sarisa has demonstrated impressive preclinical results for several indications including fibroproliferative disorders, IPF, and cancer.